arrow
H

Haibo Shao

chinese academy of medical sciences - peking union medical college
H指数:36
被引数:4,124

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitors versus lenvatinib plus PD-1 inhibitors as first-line treatment for hepatocellular carcinoma with high tumour burden and portal vein tumour thrombus (CHANCE 2416): study protocol of a multicentre, retrospective, target trial emulation design

肝动脉灌注化疗联合仑伐替尼和PD-1抑制剂与仑伐替尼联合PD-1抑制剂作为高肿瘤负荷和门静脉肿瘤血栓的肝细胞癌患者的一线治疗方案比较(CHANCE 2416):一项多中心、回顾性、目标试验模拟设计的研究方案

2025-09-090
OAAI
TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis

TACE联合酪氨酸激酶抑制剂和免疫检查点抑制剂与TACE联合酪氨酸激酶抑制剂治疗肝细胞癌的meta分析和试验序贯分析

2023-10-169
PRE
Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial
2023-05-0114
OAAI